ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 845,25
0,73%
DAX
18 869,36
0,78%
Brent Oil
82,38
-0,21%
Bitcoin
64 948,72
5,53%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) Actualités

INAB IN8bio Inc

1,14
0,10 (9,62%)
Dernière mise à jour : 18:46:38
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
IN8bio Inc INAB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 9,62% 1,14 18:46:38
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,04 0,99 1,16 1,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/5/202416:00GLOBEIN8bio Announces Upcoming Presentation at 2024 European..
13/5/202414:00GLOBEIN8bio Demonstrates Robust and Reproducible Gamma-Delta T..
09/5/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:04EDGAR2Form 8-K - Current report
09/5/202422:00GLOBEIN8bio Reports First Quarter 2024 Financial Results and..
07/5/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/4/202412:05GLOBEIN8bio Doses First Patient in Phase 2 Clinical Trial of..
24/4/202414:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
16/4/202422:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
09/4/202422:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
14/3/202421:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
05/3/202422:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
26/2/202414:00BWIN8bio to Present at Upcoming Investor Conferences
14/2/202414:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
08/2/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
18/1/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/1/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202414:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
15/12/202322:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/12/202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202312:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202312:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:15EDGAR2Form 8-K - Current report
11/12/202322:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
11/12/202315:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
11/12/202314:56EDGAR2Form 8-K - Current report
08/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:15EDGAR2Form 8-K - Current report
07/12/202314:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
05/12/202314:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
20/11/202315:04EDGAR2Form 8-K - Current report
20/11/202313:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
10/11/202313:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
09/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:03EDGAR2Form 8-K - Current report
09/11/202322:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
INAB
IN8bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés